Impedimed Limited (AU:IPD) has released an update.
ImpediMed Limited is set to reduce its operating costs by 10-15% by the end of FY24 through organizational changes and tighter cashflow management. The company has appointed Mr. Tim Benkovic as Senior Vice President of Sales and Customer Success in the U.S., along with two new business development representatives to bolster sales growth. Additionally, the company has made several high-level roles redundant and Andrew Grant has been appointed as the interim Vice President of Product Development and Customer Solutions.
For further insights into AU:IPD stock, check out TipRanks’ Stock Analysis page.
